These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 37766505)
1. Effect of dolutegravir on folate, vitamin B12 and mean corpuscular volume levels among children and adolescents with HIV: a sub-study of the ODYSSEY randomized controlled trial. Barlow-Mosha LN; Ahimbisibwe GM; Chappell E; Amuge PM; Nanduudu A; Kaudha E; Amukele T; Balamusani D; Kafufu B; Nimwesiga A; Kataike H; Namwanje R; Kasangaki G; Mulindwa A; Muzorah GA; Bbuye D; Musiime V; Mujyambere E; Ssenyonga M; Mulima D; Kyambadde RC; Namusanje J; Isabirye R; Nabalamba M; Nakirya BM; Kityo C; Kekitiinwa AR; Giaquinto C; Copp A; Gibb DM; Ford D; Musoke P; Turkova A; J Int AIDS Soc; 2023 Sep; 26(9):e26174. PubMed ID: 37766505 [TBL] [Abstract][Full Text] [Related]
2. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences. Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159 [TBL] [Abstract][Full Text] [Related]
3. A multicomponent psychosocial intervention to reduce substance use by adolescents involved in the criminal justice system: the RISKIT-CJS RCT. Coulton S; Nizalova O; Pellatt-Higgins T; Stevens A; Hendrie N; Marchand C; Vass R; Deluca P; Drummond C; Ferguson J; Waller G; Newbury-Birch D Public Health Res (Southampt); 2023 Mar; 11(3):1-77. PubMed ID: 37254608 [TBL] [Abstract][Full Text] [Related]
4. Comparison of cognitive behaviour therapy versus activity management, both delivered remotely, to treat paediatric chronic fatigue syndrome/myalgic encephalomyelitis: the UK FITNET-NHS RCT. Crawley E; Anderson E; Cochrane M; Shirkey BA; Parslow R; Hollingworth W; Mills N; Gaunt D; Treneman-Evans G; Rai M; Macleod J; Kessler D; Pitts K; Cooper S; Loades M; Annaw A; Stallard P; Knoop H; Van de Putte E; Nijhof S; Bleijenberg G; Metcalfe C Health Technol Assess; 2024 Oct; 28(70):1-134. PubMed ID: 39485730 [TBL] [Abstract][Full Text] [Related]
5. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone. Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924 [TBL] [Abstract][Full Text] [Related]
6. Safety, pharmacokinetics, and pharmacodynamics of LBP-EC01, a CRISPR-Cas3-enhanced bacteriophage cocktail, in uncomplicated urinary tract infections due to Escherichia coli (ELIMINATE): the randomised, open-label, first part of a two-part phase 2 trial. Kim P; Sanchez AM; Penke TJR; Tuson HH; Kime JC; McKee RW; Slone WL; Conley NR; McMillan LJ; Prybol CJ; Garofolo PM Lancet Infect Dis; 2024 Dec; 24(12):1319-1332. PubMed ID: 39134085 [TBL] [Abstract][Full Text] [Related]
7. Tamoxifen for adults with hepatocellular carcinoma. Naing C; Ni H; Aung HH Cochrane Database Syst Rev; 2024 Aug; 8(8):CD014869. PubMed ID: 39132750 [TBL] [Abstract][Full Text] [Related]
8. Early high-dose cryoprecipitate to reduce mortality in adult patients with traumatic haemorrhage: the CRYOSTAT-2 RCT with cost-effectiveness analysis. Curry N; Davenport R; Thomas H; Fox E; Lucas J; Evans A; Massou E; Sharma R; Shanmugaranjan S; Rourke C; Newton A; Deary A; Dallas N; Fitzpatrick-Creamer C; Podbielski JM; Wade CE; Edwards A; Benger J; Morris S; Cotton BA; Piercy J; Green L; Brohi K; Stanworth S Health Technol Assess; 2024 Nov; 28(76):1-69. PubMed ID: 39545850 [TBL] [Abstract][Full Text] [Related]
10. What Are the Functional, Radiographic, and Survivorship Outcomes of a Modified Cup-cage Technique for Pelvic Discontinuity? Mu W; Xu B; Wahafu T; Wang F; Guo W; Zou C; Cao L Clin Orthop Relat Res; 2024 Dec; 482(12):2149-2160. PubMed ID: 38991223 [TBL] [Abstract][Full Text] [Related]
11. Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial. Turkova A; White E; Kekitiinwa AR; Mumbiro V; Kaudha E; Liberty A; Ahimbisibwe GM; Moloantoa T; Srirompotong U; Mosia NR; Puthanakit T; Kobbe R; Fortuny C; Kataike H; Bbuye D; Na-Rajsima S; Coelho A; Lugemwa A; Bwakura-Dangarembizi MF; Klein N; Mujuru HA; Kityo C; Cotton MF; Ferrand RA; Giaquinto C; Rojo P; Violari A; Gibb DM; Ford D; Lancet Child Adolesc Health; 2023 Oct; 7(10):718-727. PubMed ID: 37562418 [TBL] [Abstract][Full Text] [Related]
12. "I've Spent My Whole Life Striving to Be Normal": Internalized Stigma and Perceived Impact of Diagnosis in Autistic Adults. Huang Y; Trollor JN; Foley KR; Arnold SRC Autism Adulthood; 2023 Dec; 5(4):423-436. PubMed ID: 38116050 [TBL] [Abstract][Full Text] [Related]
13. Targeted client communication via mobile devices for improving maternal, neonatal, and child health. Palmer MJ; Henschke N; Bergman H; Villanueva G; Maayan N; Tamrat T; Mehl GL; Glenton C; Lewin S; Fønhus MS; Free C Cochrane Database Syst Rev; 2020 Jul; 8(8):CD013679. PubMed ID: 32813276 [TBL] [Abstract][Full Text] [Related]
14. Strategies to improve smoking cessation rates in primary care. Lindson N; Pritchard G; Hong B; Fanshawe TR; Pipe A; Papadakis S Cochrane Database Syst Rev; 2021 Sep; 9(9):CD011556. PubMed ID: 34693994 [TBL] [Abstract][Full Text] [Related]
15. Undernutrition as a risk factor for tuberculosis disease. Franco JV; Bongaerts B; Metzendorf MI; Risso A; Guo Y; Peña Silva L; Boeckmann M; Schlesinger S; Damen JA; Richter B; Baddeley A; Bastard M; Carlqvist A; Garcia-Casal MN; Hemmingsen B; Mavhunga F; Manne-Goehler J; Viney K Cochrane Database Syst Rev; 2024 Jun; 6(6):CD015890. PubMed ID: 38860538 [TBL] [Abstract][Full Text] [Related]
17. Interventions for supporting pregnant women's decision-making about mode of birth after a caesarean. Horey D; Kealy M; Davey MA; Small R; Crowther CA Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD010041. PubMed ID: 23897547 [TBL] [Abstract][Full Text] [Related]
18. Changes to inflammatory markers during 5 years of viral suppression and during viral blips in people with HIV initiating different integrase inhibitor based regimens. Funderburg NT; Huang SSY; Cohen C; Ailstock K; Cummings M; Lee JC; Ng B; White K; Wallin JJ; Downie B; McComsey GA Front Immunol; 2024; 15():1488799. PubMed ID: 39600696 [TBL] [Abstract][Full Text] [Related]
19. Impact of switching to a dolutegravir-based regimen on body weight changes: insights from West African adult HIV cohorts. Tiendrebeogo T; Malateste K; Poda A; Minga A; Lahiri CD; Ezechi O; Ekouevi DK; Ofotokun I; Jaquet A; J Int AIDS Soc; 2024 Dec; 27(12):e26371. PubMed ID: 39604062 [TBL] [Abstract][Full Text] [Related]
20. Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model. Harnan S; Kearns B; Scope A; Schmitt L; Jankovic D; Hamilton J; Srivastava T; Hill H; Ku CC; Ren S; Rothery C; Bojke L; Sculpher M; Woods B Health Technol Assess; 2024 Oct; 28(73):1-230. PubMed ID: 39487661 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]